142 related articles for article (PubMed ID: 9918053)
1. Measurements of proteoglycan-lipoprotein interaction by gel mobility shift assay.
Hurt-Camejo E; Camejo G; Sartipy P
Methods Mol Biol; 1998; 110():267-79. PubMed ID: 9918053
[No Abstract] [Full Text] [Related]
2. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ
J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859
[TBL] [Abstract][Full Text] [Related]
3. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
Ballinger ML; Osman N; Wilks AF; Su S; Burns CJ; Bu X; Little PJ
J Cardiovasc Pharmacol; 2008 Nov; 52(5):403-12. PubMed ID: 19033819
[TBL] [Abstract][Full Text] [Related]
4. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
Olofsson SO; Borèn J
J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
[TBL] [Abstract][Full Text] [Related]
6. Hydrolytic enzymes released from resident macrophages and located in the intima extracellular matrix as agents that modify retained apolipoprotein B lipoproteins.
Camejo G
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1312-3. PubMed ID: 12909567
[No Abstract] [Full Text] [Related]
7. [Progress in the study of lipoprotein metabolism and atherosclerosis: lipoprotein metabolism of arterial wall cells and atherosclerosis].
Saito Y
Nihon Rinsho; 1988 Mar; 46(3):629-35. PubMed ID: 3404689
[No Abstract] [Full Text] [Related]
8. Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL.
Tannock LR; Little PJ; Wight TN; Chait A
J Lipid Res; 2002 Jan; 43(1):149-57. PubMed ID: 11792734
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the metabolism of lipoprotein-proteoglycan complexes in human monocyte-derived macrophages.
Vijayagopal P
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):675-81. PubMed ID: 8053893
[TBL] [Abstract][Full Text] [Related]
10. Characterization of modified low density lipoprotein subfractions by capillary isotachophoresis.
Zorn U; Haug C; Celik E; Wennauer R; Schmid-Kotsas A; Bachem MG; Grünert A
Electrophoresis; 2001 Apr; 22(6):1143-9. PubMed ID: 11358140
[TBL] [Abstract][Full Text] [Related]
11. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells.
Camejo G; Fager G; Rosengren B; Hurt-Camejo E; Bondjers G
J Biol Chem; 1993 Jul; 268(19):14131-7. PubMed ID: 8314779
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants inhibit the ability of lysophosphatidylcholine to regulate proteoglycan synthesis.
Chang MY; Han CY; Wight TN; Chait A
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):494-500. PubMed ID: 16357313
[TBL] [Abstract][Full Text] [Related]
13. [Major aspects of pathogenesis in atherosclerosis: current status and perspectives].
Titov VN
Ter Arkh; 2001; 73(12):78-82. PubMed ID: 11858118
[No Abstract] [Full Text] [Related]
14. Decorin links low-density lipoproteins (LDL) to collagen: a novel mechanism for retention of LDL in the atherosclerotic plaque.
Kovanen PT; Pentikäinen MO
Trends Cardiovasc Med; 1999; 9(3-4):86-91. PubMed ID: 10578523
[TBL] [Abstract][Full Text] [Related]
15. Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.
Rodríguez-Lee M; Ostergren-Lundén G; Wallin B; Moses J; Bondjers G; Camejo G
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):130-5. PubMed ID: 16239593
[TBL] [Abstract][Full Text] [Related]
16. Significance of acidic sugar chains of apolipoprotein B-100 in cellular metabolism of low-density lipoproteins.
Fujioka Y; Taniguchi T; Ishikawa Y; Yokoyama M
J Lab Clin Med; 2000 Nov; 136(5):355-62. PubMed ID: 11079462
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular biology: a cholesterol tether.
Staels B
Nature; 2002 Jun; 417(6890):699-701. PubMed ID: 12066168
[No Abstract] [Full Text] [Related]
18. Studies on the passage of plasma proteins across arterial endothelium in relation to atherogenesis.
Walton KW; Morris CJ
Prog Biochem Pharmacol; 1977; 13():138-52. PubMed ID: 200956
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein modification: cellular mechanisms.
Chait A; Heinecke JW
Curr Opin Lipidol; 1994 Oct; 5(5):365-70. PubMed ID: 7858911
[TBL] [Abstract][Full Text] [Related]
20. Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein--proteoglycan interaction.
Vijayagopal P; Subramaniam P
Atherosclerosis; 2001 Aug; 157(2):353-60. PubMed ID: 11472734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
